content: <?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
    <headerData>
      <submissionType>144</submissionType>
      <filerInfo>
        <filer>
          <filerCredentials>
            <cik>0001635075</cik>
            <ccc>XXXXXXXX</ccc>
          </filerCredentials>
        </filer>
        <liveTestFlag>LIVE</liveTestFlag>
  
  
      </filerInfo>
    </headerData>
    <formData>
      <issuerInfo>
        <issuerCik>0001635088</issuerCik>
        <issuerName>Roivant Sciences Ltd.</issuerName>
        <secFileNumber>001-40782</secFileNumber>
        <issuerAddress>
          <com:street1>7TH FLOOR, 50 BROADWAY</com:street1>
          <com:city>LONDON</com:city>
          <com:stateOrCountry>X0</com:stateOrCountry>
          <com:zipCode>SW1H 0DB</com:zipCode>
        </issuerAddress>
        <issuerContactPhone>441-295-5950</issuerContactPhone>
        <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>Ramaswamy Vivek</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
        <relationshipsToIssuer>
          <relationshipToIssuer>10% Stockholder</relationshipToIssuer>
        </relationshipsToIssuer>
      </issuerInfo>
      <securitiesInformation>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <brokerOrMarketmakerDetails>
          <name>Rockefeller Financial LLC</name>
          <address>
            <com:street1>45 Rockefeller Plaza Floor 5</com:street1>
            <com:city>New York City</com:city>
            <com:stateOrCountry>NY</com:stateOrCountry>
            <com:zipCode>10111</com:zipCode>
          </address>
        </brokerOrMarketmakerDetails>
        <noOfUnitsSold>273959</noOfUnitsSold>
        <aggregateMarketValue>3143286.58</aggregateMarketValue>
        <noOfUnitsOutstanding>713549458</noOfUnitsOutstanding>
        <approxSaleDate>05/06/2025</approxSaleDate>
        <securitiesExchangeName>NASDAQ</securitiesExchangeName>
      </securitiesInformation>
      <securitiesToBeSold>
        <securitiesClassTitle>Common</securitiesClassTitle>
        <acquiredDate>05/07/2014</acquiredDate>
        <natureOfAcquisitionTransaction>Founder Shares</natureOfAcquisitionTransaction>
        <nameOfPersonfromWhomAcquired>Roivant Sciences Ltd.</nameOfPersonfromWhomAcquired>
        <isGiftTransaction>N</isGiftTransaction>
        <amountOfSecuritiesAcquired>58409211</amountOfSecuritiesAcquired>
        <paymentDate>05/07/2014</paymentDate>
        <natureOfPayment>Not Applicable</natureOfPayment>
      </securitiesToBeSold>
      <nothingToReportFlagOnSecuritiesSoldInPast3Months>Y</nothingToReportFlagOnSecuritiesSoldInPast3Months>
      <noticeSignature>
        <noticeDate>05/06/2025</noticeDate>
        <signature>Jason Coleman as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Ramaswamy Vivek</signature>
      </noticeSignature>
    </formData>
  </edgarSubmission>
metadata_documents: [{"type": "144", "sequence": "1", "filename": "primary_doc.xml", "secsgml_size_bytes": 2865}]
text: 144
  0001635075
  XXXXXXXX
  LIVE
  0001635088
  Roivant Sciences Ltd.
  001-40782
  7TH FLOOR, 50 BROADWAY
  LONDON
  X0
  SW1H 0DB
  441-295-5950
  Ramaswamy Vivek
  10% Stockholder
  Common
  Rockefeller Financial LLC
  45 Rockefeller Plaza Floor 5
  New York City
  NY
  10111
  273959
  3143286.58
  713549458
  05/06/2025
  NASDAQ
  Common
  05/07/2014
  Founder Shares
  Roivant Sciences Ltd.
  N
  58409211
  05/07/2014
  Not Applicable
  Y
  05/06/2025
  Jason Coleman as a duly authorized representative of National Financial Services LLC, as attorney-in-fact for Ramaswamy Vivek